DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
According to the Rotterdam 2003 criteria, diagnosis requires the presence of at least two of the following three find­ings: hyperandrogenism, ovulatory dysfunction, and polycystic ovaries (10). The National Institutes of Health (NIH) in 1990 recommended hyperandrogenemia and oligo-anovulation as the two criteria that are required to diagnose PCOS (11). While in 2009, Androgen Excess and PCOS Society (AE-PCOS) concluded that PCOS should be based only on clinical or biochemical hyperandrogenism, and ovarian dysfunction (12). In 2012, NIH Consensus (NIH and ESHRE/ASRM) recommended broader wider Rotterdam/ESHRE/ASRM 2003 criteria with detailed PCOS phenotype of all PCOS, owing to controversies among diagnostic criteria (13). Two of the three criteria (hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology) are required for diagnosis. In addition, each case has to classify categorize into a specific definite phenotype as Phenotype A: hyperandrogenism + ovulatory dysfunction + polycystic ovarian morphology; Phenotype B: hyperandrogenism + ovulatory dysfunction; Phenotype C: hyperandrogenism + polycystic ovarian morphology; and Phenotype D: ovulatory dysfunction + polycystic ovarian morphology (14, 15).